The analyses for New York and the District of Colombia resulted in a prevalence range, rather than a single point estimate. For the purposes of this update, the midpoint of each state’s range is presented here.

Acronyms: 3+ Dose – three or more doses of HBV vaccine; HBIG – hepatitis B immunoglobulin; Tx – treated; PWID – people who inject drugs; N/A – not applicable; ND – no data; NaN – not a number

The above prevalence, diagnosed, treated and mortality estimates are based on published data.  These numbers have been updated with the most recent data.  The 2019 estimates are available, free of charge, to national hepatitis programs and collaborators upon request (requestdata@cdafound.org)

Data last updated: June 24th, 2020